Literature DB >> 32026712

Inflammatory myofibroblastic tumor of the spermatic cord: two cases and review of the literature.

Huseyin Aydemir1, Salih Budak1, Zeynep Kahyaoglu2, Sukru Kumsar3.   

Abstract

Inflammatory myofibroblastic tumor (IMT) is a neoplasm of intermediate biological potential. Few cases of spermatic cord IMT have been reported in the literature. Inflammatory myofibroblastic tumor is a consequence of the proliferation of fibroblasts and inflammatory cells. Despite its benign nature, the tumor often clinically mimics intrascrotal malignancy and usually remains undiagnosed preoperatively. The diagnosis of spermatic IMT is difficult preoperatively due to the non-specific findings. Therefore, if testicular tumors cannot be precisely excluded, radical orchiectomy should be performed for the diagnosis and treatment. However, it mainly occurs in children and young adults; spermatic IMT may also be seen among elderly men. Here, we report two cases of inflammatory myofibroblastic tumor involving the spermatic cord. SIMILAR CASES PUBLISHED: There are seven cases entitled "inflammatory myofibroblastic tumor of spermatic cord" in the literature. In our study we present two cases that had a spermatic cord IMT. Furthermore, one of these cases was 82 years of age and is the oldest patient presented in the literature.

Year:  2020        PMID: 32026712     DOI: 10.5144/0256-4947.2020.65

Source DB:  PubMed          Journal:  Ann Saudi Med        ISSN: 0256-4947            Impact factor:   1.526


  20 in total

1.  Inflammatory myofibroblastic tumor of the paratestis: sonographic appearance with pathologic correlation.

Authors:  Stylianos Megremis; Erini Papamitsaki; Panagiotis Ieromonachou; Emmanouil Zois
Journal:  J Ultrasound Med       Date:  2007-09       Impact factor: 2.153

Review 2.  IgG4-related disease: a novel lymphoproliferative disorder discovered and established in Japan in the 21st century.

Authors:  Yasufumi Masaki; Nozomu Kurose; Hisanori Umehara
Journal:  J Clin Exp Hematop       Date:  2011

3.  Inflammatory myofibroblastic tumor of spermatic cord.

Authors:  Noora Rafeek; Leena Dennis Joseph; Swaminathan Rajendiran; Cunnigaiper Dhanasekaran Narayanan
Journal:  Int J Surg Case Rep       Date:  2012-09-05

4.  Comparison of DNA ploidy, histologic, and immunohistochemical findings with clinical outcome in inflammatory myofibroblastic tumors.

Authors:  J W Hussong; M Brown; S L Perkins; L P Dehner; C M Coffin
Journal:  Mod Pathol       Date:  1999-03       Impact factor: 7.842

Review 5.  Inflammatory myofibroblastic tumor of the epididymis: case report and review of the literature.

Authors:  Hari Tunuguntla; Anubha Mishra; Merce Jorda; Rafael Gosalbez
Journal:  Urology       Date:  2010-12-13       Impact factor: 2.649

6.  [Inflammatory myofibroblastic genitourinary tumor: The challenge of controlling and monitoring an non frequent oncological disease.]

Authors:  Luis Rico; Francisco Miguel López; Gonzalo Vitagliano; Ameri Carlos
Journal:  Arch Esp Urol       Date:  2017-03       Impact factor: 0.436

Review 7.  Successful treatment of inflammatory myofibroblastic tumor with malignant transformation by surgical resection and chemotherapy.

Authors:  Megan K Dishop; Brad W Warner; Louis P Dehner; Vesna M Kriss; Martha F Greenwood; John D Geil; Jeffrey A Moscow
Journal:  J Pediatr Hematol Oncol       Date:  2003-02       Impact factor: 1.289

8.  Inflammatory myofibroblastic tumor of spermatic cord in undescended testis.

Authors:  Chi-Hang Yee; Ka-Fai To; See-Ming Hou; Chi-Fai Ng
Journal:  Urology       Date:  2008-06-06       Impact factor: 2.649

9.  Inflammatory myofibroblastic tumors harbor multiple potentially actionable kinase fusions.

Authors:  Christine M Lovly; Abha Gupta; Doron Lipson; Geoff Otto; Tina Brennan; Catherine T Chung; Scott C Borinstein; Jeffrey S Ross; Philip J Stephens; Vincent A Miller; Cheryl M Coffin
Journal:  Cancer Discov       Date:  2014-05-29       Impact factor: 39.397

10.  Inflammatory myofibroblastic sarcoma of the spermatic cord.

Authors:  Nilay Chakrabarti; Ratnakar Shetty
Journal:  Indian J Surg       Date:  2010-07-01       Impact factor: 0.656

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.